# US 2022/0031483 A1 · Stent and method of making same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031483 A1
- Document ID: US20220031483A1
- Status: Published application
- Kind: A1
- Application number: 17/372,990
- Filed: 2021-07-12
- Published: 2022-02-03
- Earliest claimed: 2019-02-27
- Assignees: Vactronix Scientific, LLC
- Applicants: Vactronix Scientific LLC
- Inventors: Scott P. Carpenter; Julio C. Palmaz
- Web page: https://patentgrep.com/patent/US20220031483A1

## CPC

- A61F 2/915: with bands having a meander structure, adjacent bands being connected to each other
- A61F 2/95: Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F 2002/825: {having longitudinal struts}
- A61F 2002/91533: {characterised by the phase between adjacent bands}
- A61F 2002/91558: {connected peak to peak}
- A61F 2002/91566: {connected trough to trough}
- A61F 2210/0014: using shape memory or superelastic materials, e.g. nitinol
- A61F 2230/0054: V-shaped
- A61F 2240/001: Designing or manufacturing processes
- A61F 2250/0026: differing in surface structures
- A61F 2250/0067: Means for introducing or releasing pharmaceutical products into the body
- A61F 2250/0068: the pharmaceutical product being in a reservoir
- A61F 2250/0098: radio-opaque, e.g. radio-opaque markers
- A61L 2420/02: Methods for coating medical devices
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A stent for vascular interventions having a hybrid open cell geometry. Variants of the stent include bare metal stents and drug-eluting stents. Embodiments of the stent include end projections for radiopaque markers or a discontinuous partial radiopaque coating on low-stress or low-strain regions of the peripheral stent. The stents of the invention are characterized by having thin walls, nested rows of struts, high expansion ratio, high and uniform radial force over entire diametric size and length of device, crush resistance up to and including about 90% of its fully expanded diameter, high fatigue resistance and high corrosion resistance.

## Claims

### Claim 1

A method of making a stent, comprising the steps of:
a. Providing a stent hypotube;
b. Patterning the stent hypotube with a stent pattern;
c. Forming a plurality of volume-enhancing features in or on an outer abluminal surface of the stent pattern;
d. Releasing the stent pattern from the stent hypotube; and
e. Coating the outer abluminal surface of the stent pattern with a drug-release coating and at least substantially filling the plurality of volume-enhancing features.

### Claim 2 (depends on 1)

The method of claim 1, wherein the step of providing a stent hypotube further comprises the step of making the stent hypotube from a binary, ternary or quaternary shape memory or superelastic material.

### Claim 3 (depends on 2)

The method of claim 2, wherein the step of making a stent hypotube further comprises the step of alloying a radiopaque material with shape memory or superelastic material.

### Claim 4 (depends on 1)

The method of claim 1, further comprising the step of coating at least a portion of the released stent pattern with a radiopaque material prior to conducting step e.

### Claim 5 (depends on 1)

The method of claim 1, further comprising the step of coating low-stress regions of the released stent with a radiopaque material.

### Claim 6 (depends on 1)

The method of claim 1, wherein the step of patterning the stent hypotube further comprises the steps of:
a. Forming a plurality of generally sinusoidal circumferential ring members having peaks and valleys;
b. Forming a plurality of bridge members interconnecting adjacent pairs of sinusoidal circumferential ring members;
c. Forming a plurality of projection members extending from at least one of a proximal and a distal generally sinusoidal circumferential ring member at proximal and/or distal ends of the stent; and
d. And covering the entire outer abluminal surface of the stent with a drug eluting layer and at least partially filling the plurality of volume-enhancing features.

### Claim 7 (depends on 6)

The method of claim 6, wherein the plurality of sinusoidal circumferential ring members is configured to nest with adjacent sinusoidal circumferential ring members when the stent is in a diametrically unexpanded state.

### Claim 8 (depends on 7)

The method of claim 7, wherein the plurality of sinusoidal circumferential ring members further has a substantially zig-zag configuration.

### Claim 9 (depends on 8)

The method of claim 8, further comprising an offset section intermediate circumferentially adjacent peaks and valleys of each circumferential ring member.

### Claim 10 (depends on 6)

The method of claim 6, wherein the plurality of generally sinusoidal circumferential ring members and the plurality of bridge members have a wall thickness between about 50 μm and about 100 μm.

### Claim 11 (depends on 6)

The method of claim 6, wherein the plurality of volume-enhancing features have a depth between about 0.5 μm and about 10 μm.

### Claim 12 (depends on 11)

The method of claim 11, wherein the plurality of volume-enhancing features have a spacing of about 2 μm and about 10 μm between adjacent volume-enhancing features.

### Claim 13 (depends on 6)

The method of claim 6, wherein each of the plurality of volume-enhancing features have a width between 0.5 and 10 μm.

### Claim 14 (depends on 8)

The method of claim 8, wherein each of the plurality of volume-enhancing features have a width to depth ration between about 1:1 and 1:3.

### Claim 15 (depends on 6)

The method of claim 6, wherein the drug eluting layer substantially fills the plurality of grooves and has a thickness of between about 3 μm to about 20 μm from the outer abluminal surface of the stent.

### Claim 16 (depends on 1)

The method of claim 1, wherein the plurality of volume-enhancing features are formed in the plurality of sinusoidal circumferential ring members and in the plurality of bridge members.

### Claim 17 (depends on 1)

The method of claim 1, wherein each of the plurality of projection members further comprises a substantially quadrilateral frame having a central open region.

### Claim 18 (depends on 12)

The method of claim 12, further comprising a radiopaque cuff member joined to the plurality of projection members.

### Claim 19 (depends on 13)

The method of claim 13, wherein the radiopaque cuff member has a portion thereof recessed within the central open region.

### Claim 20 (depends on 1)

The method of claim 1, further comprising a radiopaque coating on at least a portion of the outer abluminal surface of the stent.

### Claim 21 (depends on 1)

The method of claim 1, wherein the plurality of circumferential ring members and the plurality of bridge members further define a plurality of open cells.

### Claim 22 (depends on 16)

The method of claim 16, wherein the plurality of open cells further comprises at least two different open cell configurations.

### Claim 23 (depends on 17)

The method of claim 17, where the at least two different open cell configurations further comprise a first open cell configuration positioned at or proximate to opposing ends of the stent and a second open cell configuration positioned along an intermediate portion of the stent.

### Claim 24 (depends on 18)

The method of claim 18, wherein the first open cell configuration further comprises a generally V-shaped open cell configuration.

### Claim 25 (depends on 19)

The method of claim 19, wherein the second open cell configuration further comprises a generally Z-shaped open cell configuration.

### Claim 26 (depends on 1)

The method of claim 1, wherein the plurality of volume-enhancing features further comprise a plurality of elongate grooves.

### Claim 27 (depends on 21)

The method of claim 21, wherein the plurality of elongate grooves are oriented substantially parallel to a longitudinal axis of the stent.
